Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) EPS (Weighted Average and Diluted): 2024-2025

Historic EPS (Weighted Average and Diluted) for Pyxis Oncology (PYXS) over the last 2 years, with Sep 2025 value amounting to -$0.35.

  • Pyxis Oncology's EPS (Weighted Average and Diluted) changed negligibly% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.59, marking a year-over-year change of. This contributed to the annual value of -$1.32 for FY2024, which is 28.65% up from last year.
  • Pyxis Oncology's EPS (Weighted Average and Diluted) amounted to -$0.35 in Q3 2025, which was down 16.67% from -$0.30 recorded in Q2 2025.
  • Pyxis Oncology's 5-year EPS (Weighted Average and Diluted) high stood at -$0.06 for Q1 2024, and its period low was -$0.59 during Q4 2024.
  • Over the past 2 years, Pyxis Oncology's median EPS (Weighted Average and Diluted) value was -$0.35 (recorded in 2025), while the average stood at -$0.33.
  • Data for Pyxis Oncology's EPS (Weighted Average and Diluted) shows a maximum YoY tumbled of 483.33% (in 2025) over the last 5 years.
  • Over the past 2 years, Pyxis Oncology's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.59 in 2024, then remained steady at -$0.35 in 2025.
  • Its last three reported values are -$0.35 in Q3 2025, -$0.30 for Q2 2025, and -$0.35 during Q1 2025.